Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
about
State-dependent μ-opioid modulation of social motivationSimultaneous fMRI-PET of the opioidergic pain system in human brainThe Neurobiology Shaping Affective Touch: Expectation, Motivation, and Meaning in the Multisensory ContextHypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditionsA key role of the basal ganglia in pain and analgesia--insights gained through human functional imagingInvestigating expectation and reward in human opioid addiction with [(11) C]raclopride PETNeuropsychological Functions of μ- and δ-Opioid Systems.Genetic Polymorphisms in the Dopamine Receptor 2 Predict Acute Pain Severity after Motor Vehicle Collision.What to learn from in vivo opioidergic brain imaging?Addiction: the clinical interface.Neural vulnerability factors that increase risk for future weight gain.Endogenous opioid-dopamine neurotransmission underlie negative CBV fMRI signalsThe effect of intravenous lidocaine on brain activation during non-noxious and acute noxious stimulation of the forepaw: a functional magnetic resonance imaging study in the rat.Therapeutic Utility of Opioids for Restless Legs Syndrome.Central nervous system effects of haloperidol on THC in healthy male volunteers.
P2860
Q22305623-36E4D25A-FBAF-45D4-B845-E706569AAD0DQ24580478-434F3716-4D95-4B2A-A6B7-0DC36F6E2B12Q26771487-7EC4979C-567E-4C7B-B69B-2765B4B6DABBQ33902600-7DF0FB3C-64AE-4475-A6B3-8822F00EE259Q33907230-F166D194-92B5-4290-AFE9-82DA27B3310FQ34803278-DE0504C9-39F5-44D3-8C1D-37DB22946E45Q35361350-9C8A479A-F539-4CAC-A647-9B0553A29759Q35563650-8CDA4D26-DCBC-422D-B185-1547D4D8BF1DQ36057731-687A5E08-1859-45B9-ACB6-3487630F63D5Q36741908-B2B5F03A-4064-4ECD-B669-683D0DD93C2BQ36777473-9894D95D-31D1-4DD7-9CEF-77CDCC8C5549Q37070303-7AFC1B69-BCFC-4F1A-82A4-F8A554687BCBQ37189423-54315B19-C46A-4C1A-9566-2542966ECECDQ39154225-BDF2A2F7-A002-4C95-A798-78E8ACEBC84FQ43168358-127CD22E-D12C-48A3-BD31-B023FBF6F2B3
P2860
Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Mu-receptor agonism with alfen ...... ne D2 receptor binding in man.
@en
Mu-receptor agonism with alfen ...... ne D2 receptor binding in man.
@nl
type
label
Mu-receptor agonism with alfen ...... ne D2 receptor binding in man.
@en
Mu-receptor agonism with alfen ...... ne D2 receptor binding in man.
@nl
prefLabel
Mu-receptor agonism with alfen ...... ne D2 receptor binding in man.
@en
Mu-receptor agonism with alfen ...... ne D2 receptor binding in man.
@nl
P2093
P2860
P356
P1433
P1476
Mu-receptor agonism with alfen ...... ne D2 receptor binding in man.
@en
P2093
Jaana K Kajander
Jarmo Hietala
Kjell Någren
Nora Hagelberg
Susanna Hinkka
P2860
P356
10.1002/SYN.10078
P577
2002-07-01T00:00:00Z